Patent · US Expired

Treatment of cancer with carcinostatic and immunostimulating agent containing lysophospholipid and phospholipid

US4372949A · kind A · utility

107Cited by
2References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 29, 1980
Grant dateFeb 8, 1983
Priority date
Expiry dateFeb 29, 2000

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K31/685
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A carcinostatic and immunostimulating agent containing a lysophospholipid and a phospholipid. Said carcinostatic and immunostimulating agent is useful for the treatment of cancerous diseases of the mammals including human being. This disclosure concerns such a carcinostatic and immunostimulating agent and a process for preparing the same as well as a method for treating the cancerous diseases by using said agent.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.